Cryoport Intrinsic Value – Cryoport Offers Unique Value in the Life Science Industry – Zach Bristow
February 10, 2023

Trending News ☀️
Cryoport Intrinsic Value – Zach Bristow recently wrote an article on Seeking Alpha discussing the unique value that Cryoport ($NASDAQ:CYRX), a leading provider of temperature-controlled supply chain solutions and services, offers to the life sciences industry. He highlights the company’s mission to provide innovative solutions and services to safely and effectively transport biological materials, such as vaccines and biopharmaceuticals, around the world. It is a publicly traded company on the NASDAQ exchange under the ticker symbol CYRX. The company has a portfolio of products and services designed to meet the needs of the life sciences industry and ensure the safe and reliable transport of highly sensitive temperature-controlled products. These include cryogenic shippers and storage systems, as well as logistics and software solutions. Cryoport’s solutions are tailored to meet the challenges of transporting temperature-sensitive products and biological materials.
The company has established a global network of distribution centers and specialized logistics to ensure a safe and efficient delivery process from origin to destination. Through its software solutions, Cryoport also provides customers with real-time tracking and data analytics, allowing them to monitor shipments from anywhere in the world. Cryoport provides an invaluable service to the life sciences industry, which is driven by innovation and new technologies. With its comprehensive portfolio of products and services, Cryoport is well-positioned to capitalize on the growth of this sector. Zach Bristow’s article on Seeking Alpha provides insight into the unique value that Cryoport offers to its customers and investors.
Stock Price
Cryoport, a leader in the life sciences industry, is currently receiving mostly positive news sentiment. On Wednesday, CRYOPORT stock opened at $23.8 and closed at $22.6, a drop of 6.3% from the last closing price of 24.1. Cryoport offers a unique value proposition to life science companies facing the challenge of managing complex and time-sensitive shipments of temperature-sensitive products. The company’s proprietary Cryoportal Logistics Platform provides an integrated suite of services that helps manage the entire shipment process from start to finish, including shipment tracking and visibility, regulatory compliance, and analytics. What sets Cryoport apart from other logistics providers is its focus on providing cold chain solutions tailored to life science companies. Cryoport also offers a variety of value-added services, such as inventory management, temperature monitoring, packaging optimization, and product life cycle management.
This allows customers to optimize their business processes and maximize their supply chain efficiency. With its extensive experience in the life sciences industry, Cryoport is well-positioned to provide customers with the highest quality of service and support. Despite the 6.3% drop in stock price on Wednesday, investors remain optimistic that Cryoport will continue to deliver on its promise of delivering superior services to life science companies. Whether it’s providing cold chain solutions or offering value-added services, Cryoport is committed to helping its customers succeed in the life sciences industry. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Cryoport. More…
| Total Revenues | Net Income | Net Margin |
| 233.36 | -295.98 | -18.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cryoport. More…
| Operations | Investing | Financing |
| -2.89 | -262.78 | 254.71 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cryoport. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.03k | 478.07 | 11.72 |
Key Ratios Snapshot
Some of the financial key ratios for Cryoport are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 97.3% | – | -121.0% |
| FCF Margin | ROE | ROA |
| -11.6% | -31.4% | -17.1% |
Analysis – Cryoport Intrinsic Value
GoodWhale has conducted an analysis of CRYOPORT’s wellbeing and determined that its intrinsic value stands at approximately $69.7. This figure was determined using GoodWhale’s proprietary Valuation Line, which takes into account factors such as the company’s projected future earnings and the current market value of its equity. The current market price of a CRYOPORT share is $22.6, which implies that the stock is undervalued by 67.6%. The discrepancy between the intrinsic value and the market price provides investors with an opportunity to purchase CRYOPORT stock at a discount. It is important to note, however, that this discounted rate may not remain stable in the long-term, and investors are advised to conduct their own due diligence before making any investment decisions. More…
Peers
In the logistics and transportation industry, there is intense competition among companies to provide the most efficient and cost-effective services. This is especially true for companies specializing in cryogenic transportation, where time and temperature sensitive shipments are the norm. In this arena, CryoPort Inc. has been a leader, innovating and investing in cutting-edge technology to stay ahead of the competition. Some of its main competitors include Shenzhen Prolto Supply Chain Management Co Ltd, Xinjiang Tianshun Supply Chain Co Ltd, and BEST Inc. While each company has its own strengths and weaknesses, CryoPort has consistently remained at the forefront of the industry, providing superior service and value to its customers.
– Shenzhen Prolto Supply Chain Management Co Ltd ($SZSE:002769)
Shenzhen Prolto Supply Chain Management Co Ltd has a market cap of 3.23B as of 2022, and a Return on Equity of 2.47%. The company is engaged in the business of providing supply chain management services. It offers services such as logistics, transportation, warehousing, and distribution. The company has a network of over 1,000 warehouses in China.
– Xinjiang Tianshun Supply Chain Co Ltd ($SZSE:002800)
Xinjiang Tianshun Supply Chain Co Ltd is a Chinese company that operates in the logistics and supply chain management industry. The company has a market capitalization of 2.2 billion US dollars as of 2022 and a return on equity of 6.85 percent. Xinjiang Tianshun Supply Chain Co Ltd is headquartered in the city of Urumqi in the Xinjiang Uyghur Autonomous Region of China. The company was founded in the year 2006.
– BEST Inc ($NYSE:BEST)
BEST Inc. is a leading express delivery and logistics company in China, with a market cap of $49.1 million as of 2022. The company has a return on equity of -60.92%. BEST Inc. provides express delivery, warehousing, and logistics services in China. The company operates a network of over 30,000 stores and more than 200 warehouses across China.
Summary
CRYOPORT is a company that offers unique value in the life sciences industry, and its stock price has recently taken a downturn despite generally positive news sentiment. Investing analysis suggests that CRYOPORT is an attractive option for investors due to its unique position in the life sciences industry, offering potential long-term growth. While its stock price has dropped, investors may be able to capitalize on any potential upside by buying shares at a lower cost. As always, it is important to research thoroughly before investing in any stock.
Recent Posts









